Back to the main directory
Press Release
- Fluence Energy, Inc. Announces Third Quarter 2024 Earnings Release Date, Conference Call and Webcast by GlobeNewsWire
- Above Food Provides Business Update by GlobeNewsWire
- WEBTOON Entertainment Inc. to Report Second Quarter 2024 Financial Results on August 8, 2024 by GlobeNewsWire
- Verisign Reports Second Quarter 2024 Results by BusinessWire
- QuinStreet Sets Date to Announce Fiscal Fourth Quarter and FY2024 Results by BusinessWire
- Applied Optoelectronics Confirms No Material Impact to Operations from Typhoon Gaemi by GlobeNewsWire
- The Ensign Group Reports Second Quarter 2024 Results; Raises Annual Earnings and Revenue Guidance by GlobeNewsWire
- Cenovus to hold second-quarter conference call and webcast on August 1 by GlobeNewsWire
- Montauk Renewables Schedules Second Quarter 2024 Conference Call for Thursday, August 8, 2024, at 5:00 p.m. ET by GlobeNewsWire
- Ocean Power Technologies, Inc. Announces Fourth Quarter and Full Year Fiscal 2024 Results by GlobeNewsWire
- Sezzle to Announce Second Quarter 2024 Results by GlobeNewsWire
- MidWestOne Financial Group, Inc. Reports Financial Results for the Second Quarter of 2024 by GlobeNewsWire
- Midland States Bancorp, Inc. Announces 2024 Second Quarter Results by GlobeNewsWire
- Phillips Edison & Company Acquires Grocery-Anchored Shopping Center in Partnership with Cohen & Steers Income Opportunities REIT, Inc. by GlobeNewsWire
- Hilton Grand Vacations to Report Second Quarter 2024 Results by BusinessWire
- Resources Connection, Inc. Announces Quarterly Dividend and Dividend Payment Date by BusinessWire
- Eastman Announces Second-Quarter 2024 Financial Results by BusinessWire
- Dime Community Bancshares Declares Quarterly Cash Dividend for Series A Preferred Stock by GlobeNewsWire
- First Business Bank Reports Second Quarter 2024 Net Income of $10.2 Million by BusinessWire
- Travere Therapeutics to Report Second Quarter 2024 Financial Results by GlobeNewsWire
- Comstock Inc. to Host Q2 Earnings Call on August 8, 2024, at 4:30pm ET by GlobeNewsWire
- FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment by GlobeNewsWire
- Coherent Corp. Reaches Milestone in Thirty Meter Telescope (TMT) Project by GlobeNewsWire
- Seacoast Reports Second Quarter 2024 Results by GlobeNewsWire
- 23andMe to Report Q1 FY2025 Financial Results by GlobeNewsWire